The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cisplatin monotherapy as a treatment option for patients with HER-2–negative breast cancer facing hepatic visceral crisis or impending visceral crisis: A single-center cohort study.
 
Miroslawa Puskulluoglu
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Gilead Sciences; Janssen; Novartis; Roche
Travel, Accommodations, Expenses - Gilead Sciences
 
Aleksandra Grela-Wojewoda
Speakers' Bureau - BMS, Pierre Fabre, Roche, Amgen, , MSD, Gilead and Pfizer.
Travel, Accommodations, Expenses - BMS, Pierre Fabre, Roche, Amgen, , MSD, Gilead and Pfizer.
 
Renata Pacholczak-Madej
Honoraria - Bristol Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Agnieszka Pietruszka
Speakers' Bureau - Novartis, MSD, Amgen
 
Małgorzata Pieniążek
Speakers' Bureau - Gilead Sciences
Travel, Accommodations, Expenses - Pfizer and Novartis
 
Agnieszka Rudzińska
Travel, Accommodations, Expenses - Sandoz
 
Joanna Lompart
Speakers' Bureau - Pierre Fabre, Roche, MERK, Ipsen
Travel, Accommodations, Expenses - Pierre Fabre, MSD, Novartis
 
Tomasz Kopciński
Honoraria - Novartis, Merck
Travel, Accommodations, Expenses - EGIS,MSD, Roche
 
Ewa Pasieka
Honoraria - Pierre Fabre, Amgen
Travel, Accommodations, Expenses - Egis, Ipsen, BMS, Novartis
 
Marek Ziobro
Consulting or Advisory Role - Bristol Myers Squibb; Ipsen; MSD; Novartis; Pierre Fabre
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche